Fresh analysis indicates that individuals who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who end conventional lifestyle plans.
Research printed in a leading medical journal points out that while overweight people often shed substantial amounts of their body weight while using the jabs, the weight comes back at an average rate of nearly a kilo each month once they quit.
"Individuals purchasing such treatments should be aware of the danger of quick weight regain when the therapy concludes," warns expert Dr. Susan Jebb.
That rate of recovery means a return to pre-treatment weight within about a year and a half.
Analyzing Approaches
The analysis, which looked at 37 of trials involving thousands of participants, contrasted the results of the injectable medications with conventional dieting.
Researchers emphasize that individuals who shed pounds through dieting usually experience a more gradual weight regain—perhaps 100 grams monthly—after stopping.
Understanding the Fast Rebound
Nutrition scientists propose the mode of action of the drugs accounts for the heightened rebound.
The injections copy a natural hormone called GLP-1, which moderates appetite.
"Sustained high doses of GLP-1 levels far above than the body's typical production might result in the body to produce less of its endogenous GLP-1, and could reduce responsiveness to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication means hunger is no longer kept in check, making excessive eating far more likely."
An Ongoing Condition?
Health authorities recommend the jabs for people with weight-linked medical conditions, accompanied by recommended lifestyle changes.
Many experts contend that, given the likelihood of weight regain, the treatment might need to be long-term.
This perspective is echoed by drug manufacturers, who say that the findings "underscore the persistent character of excess weight," akin to managing conditions like hypertension.
User Testimonies
People who have stopped the medication report a intense return of hunger.
"I experienced a trigger that goes on and you become ravenous," described a patient.
This challenge is exacerbated if individuals have not adopted lasting dietary or behavioural modifications during treatment.
Growing Adoption
Survey data show that a significant number of adults in the UK have tried these injections in the last 12 months, with interest being substantial.
- Adoption is more common among women compared to males.
- The middle-aged age group shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than the NHS.
Finally, experts caution that while these medications are effective agents for shedding pounds, they are not a permanent fix and maintained weight loss relies on integrated behavioural support.
